Thanks very much for your patience as we work diligently to re-launch the Life Science Deal Flow blog. We will be back on online Monday 19 October, not necessarily rested rather getting after it to bring you the latest on early-stage therapeutic, diagnostic and device companies – the news breaking, the funds raised, the investors participating, the technologies pursued, the trials designed, the data yielded, the regulatory pathway pursued and the products and indications approved.

Keep in mind Life Science Deal Flow is not a one-way conversation, your perspective and participation will elevate and catalyze a much more sophisticated dialogue. This anti-tête-à-tête will transpire in each post in the comment section, so don’t be shy!

Have some questions or comments? Perhaps even some hot leads to provide? Fear not – you say *confidential* and it goes in the vault. Click on over to the CONTACT page to get a hold of Life Science Deal Flow. Thanks again for your interest in the content and support of our new site. We’ll be right back…